The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

(RTTNews) - AbbVie, Inc. (ABBV) and biotechnology company Aliada Therapeutics announced Monday a definitive agreement under which AbbVie will acquire all outstanding Aliada equity for $1.4 billion in ...

AbbVie has agreed to buy Aliada Therapeutics, a biotechnology company backed by Johnson & Johnson, for $1.4 billion in cash in a deal that adds a potential therapy for Alzheimer’s disease to AbbVie’s ...

This acquisition will bring Aliada’s Alzheimer’s treatment under AbbVie’s pipeline. AbbVie announced the completion of its acquisition of Aliada Therapeutics. 1 As a result, Aliada’s lead ...

The collaboration will focus on multiple enzyme cargoes modified using Aliada's modular delivery platform The collaboration will focus on multiple enzyme cargoes modified using Aliada’s modular ...

AbbVie is buying Aliada Therapeutics for $1.4 billion. It is AbbVie’s third acquisition this year and its first in the neuroscience space since the firm bought Cerevel Therapeutics and its late-stage ...

AbbVie has announced that it will be acquiring Aliada Therapeutics for $1.4bn, marking a notable boost to its neuroscience pipeline. The deal gives AbbVie access to Aliada’s therapies that use a novel ...

The Mexican startup Homely, a platform that links cleaning professionals with businesses, offices and homes, announced the acquisition of Aliada, its main competitor in domestic services to expand its ...